EPAM Systems (EPAM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
CEO Arkadiy Dobkin will transition to Executive Chairman on September 1, 2025, focusing on strategic initiatives and continuity of the company's mission.
Balazs Fejes, current President of Global Business and Chief Revenue Officer, will become CEO and President upon Dobkin's transition.
The supplement updates the proxy statement for the 2025 Annual Meeting scheduled for May 22, 2025, and all other information remains unchanged.
Board of directors and corporate governance
Dobkin, as Executive Chairman, will maintain key relationships and provide guidance on strategic initiatives.
Fejes brings extensive leadership experience within the company, having served in multiple executive roles since 2004.
Voting matters and shareholder proposals
Shareholders are informed of the CEO succession and can change or revoke their votes as outlined in the proxy statement.
Latest events from EPAM Systems
- Accelerating as an AI-native leader, targeting 16%+ margins and $1.8B+ free cash flow by 2028.EPAM
Investor Day 202612 Mar 2026 - Strong 2025 growth and AI momentum support a robust 2026 outlook for revenue and EPS.EPAM
Q4 202519 Feb 2026 - Q2 revenue down 2% YoY; healthcare strong, margins lower, new $500M buyback approved.EPAM
Q2 20242 Feb 2026 - Q3 revenue and EPS rose, NEORIS acquisition expanded reach, and share buybacks accelerated.EPAM
Q3 202416 Jan 2026 - Q4 2024 delivered strong growth and 2025 guidance targets double-digit revenue gains.EPAM
Q4 202413 Dec 2025 - Board declassification, majority voting, and new incentive plan headline 2025 proxy.EPAM
Proxy Filing1 Dec 2025 - Proxy seeks approval for board declassification, majority voting, and new long-term incentive plan.EPAM
Proxy Filing1 Dec 2025 - Key votes include director elections, governance reforms, and executive pay approval.EPAM
Proxy Filing1 Dec 2025 - Q2 revenue up 18% year-over-year; full-year outlook raised, margins pressured by higher costs.EPAM
Q2 202523 Nov 2025